• 1 March 2019

    A big future awaits small-size antibodies

    Nanobodies are composed of the target-binding fragments of monoclonal antibodies; they are significantly smaller in size than traditional monoclonal antibodies, have enhanced chemical properties, and they can access and lodge...

  • 1 March 2019

    New biomarkers hold great potential in prostate cancer

    More than 300 posters addressed recent findings in prostate cancer treatment and research at the American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium, held between February 14–16.

Go Top